Renal Outcome in Patients With COVID-19

  • STATUS
    Recruiting
  • End date
    Jun 30, 2022
  • participants needed
    900
  • sponsor
    University of Giessen
Updated on 12 September 2021
respiratory distress
covid-19
renal injury

Summary

Acute kidney injury (AKI) is reported to occur in 0.5-9% of severe acute respiratory distress coronavirus 2-positive patients and AKI has been identified as an independent risk factor for in-hospital mortality. The present study aims to investigate the incidence of renal outcome of in-hospital patients diagnosed with COVID-19.

Description

Beginning in December 2019, a novel coronavirus, designated as severe acute respiratory distress coronavirus 2 (SARS-CoV-2), has caused an international outbreak of respiratory illness termed coronavirus disease 2019 (COVID-19). Although the clinical manifestations of COVID-19 are dominated by respiratory symptoms, some patients show severe kidney abnormalities. Acute kidney injury (AKI) is reported to occur in 0.5-9% of SARS-CoV-2 positive patients and AKI has been identified as an independent risk factor for in-hospital mortality. The present study aims to investigate the incidence of of renal outcome of in-hospital patients diagnosed with COVID-19.

Details
Condition Coronavirus Infection, Renal Failure, Acute renal failure, Coronavirus, Kidney Failure (Pediatric), Corona Virus Infection, Kidney Failure, acute kidney injury, acute kidney injuries
Clinical Study IdentifierNCT04353583
SponsorUniversity of Giessen
Last Modified on12 September 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Patients with COVID-19 diagnosed by World Health Organisation (WHO) criteria

Exclusion Criteria

Patients aged less than 18 years
Patients with stage-5 chronic kidney disease
Patients receiving maintenance dialysis
Recipients of solid-organ transplantation
Patients with AKI requiring renal replacement therapy
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note